Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.


Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 21 5 2020
medline: 3 11 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

To determine whether limb-based patency (LBP) after infrainguinal revascularization for chronic limb-threatening ischemia (CLTI) is similar between bypass surgery and endovascular therapy (EVT). The database for the The bypass surgery group had a higher stage of limb severity (WIfI) and anatomic complexity (GLASS) than the EVT group, whereas the EVT group had a higher prevalence of heart failure. Both SPP- and ABI-based LBP rates were higher in the bypass group than in the EVT group. SPP-based LBP rates at 3 months were 73.8% (95% CI 63.4% to 84.2%) in the bypass group and 46.2% (95% CI 38.5% to 53.8%) in the EVT group; the corresponding ABI-based LBP rates were 71.5% (95% CI 61.8% to 81.2%) and 44.0% (95% CI 37.3% to 50.7%). LBP is an important concept in the new global vascular guidelines for assessing the anatomic and hemodynamic status of CLTI patients. The present study found that LBP was significantly lower in the EVT group vs the bypass surgery group.

Identifiants

pubmed: 32431246
doi: 10.1177/1526602820923388
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

584-594

Commentaires et corrections

Type : CommentIn

Auteurs

Makoto Utsunomiya (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Mitsuyoshi Takahara (M)

Department of Metabolic Medicine and Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Osamu Iida (O)

Cardiovascular Division, Kansai Rosai Hospital, Amagasaki, Japan.

Yoshimitsu Soga (Y)

Cardiovascular Medicine, Kokura Memorial Hospital, Kitakyushu, Japan.

Yosuke Hata (Y)

Cardiovascular Division, Kansai Rosai Hospital, Amagasaki, Japan.

Tatsuya Shiraki (T)

Cardiovascular Medicine, Osaka University, Osaka, Japan.

Ayumu Nagae (A)

Cardiovascular Medicine, Shinshu University, Nagano, Japan.

Tamon Kato (T)

Cardiovascular Medicine, Shinshu University, Nagano, Japan.

Norihiro Kobayashi (N)

Cardiovascular Medicine, Saiseikai Yokohama Tobu Hospital, Yokohama, Japan.

Nobuhiro Suematsu (N)

Cardiovascular Medicine, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.

Junichi Tasaki (J)

Cardiovascular Medicine, Kyoto University, Kyoto, Japan.

Kazunori Horie (K)

Cardiovascular Medicine, Sendai Kosei Hospital, Sendai, Japan.

Daiki Uchida (D)

Department of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.

Akio Kodama (A)

Division of Vascular Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Nobuyoshi Azuma (N)

Department of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.

Masato Nakamura (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH